selected publications
- Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1. Journal of endocrinological investigation. 2026 Academic Article GET IT
- Tirzepatide Heralds the Hope of Chronic Disease Eradication. The Journal of clinical endocrinology and metabolism. 2026 Academic Article GET IT
- TOS/OMA/OAC Expert Guidance Statement on Obesity Pharmacotherapy: A Humbling Call to Action. Obesity (Silver Spring, Md.). 2026 Academic Article GET IT
-
The important role of comorbidities in the management of obesity.
Journal of the Endocrine Society.
2026
Information Resource
GET IT
Times cited: 1 -
Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study.
Obesity (Silver Spring, Md.).
2025
Academic Article
GET IT
Times cited: 1 - Primordial Care-The Space in Between. JAMA. 2025 Academic Article GET IT
-
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee.
Journal of the American College of Cardiology.
2025
Information Resource
GET IT
Times cited: 31 -
Adverse effects of obesity on overall health, quality of life, and related physical health metrics: A cross-sectional and longitudinal study from the All of Us Research Program.
Journal of internal medicine.
2025
Academic Article
GET IT
Times cited: 3 -
Associations between Class I, II, or III Obesity and Health Outcomes.
NEJM evidence.
2025
Academic Article
GET IT
Times cited: 35 -
Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program.
Obesity (Silver Spring, Md.).
2025
Academic Article
GET IT
Times cited: 5 -
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.
Obesity (Silver Spring, Md.).
2025
Academic Article
GET IT
Times cited: 4 -
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
2024
Article
GET IT
Times cited: 1 -
Navigating the Predictive Landscape: DiaRem's Role in Unveiling Outcomes for Diabetes Remission following ESG.
Obesity surgery.
2024
Academic Article
GET IT
Times cited: 8 -
Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.
The Journal of clinical endocrinology and metabolism.
2023
Academic Article
GET IT
Times cited: 20 -
Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience.
Frontiers in clinical diabetes and healthcare.
2023
Academic Article
GET IT
Times cited: 13 - Letter to the Editor of ObesityPillars from the Obesity Medicine Fellowship Council. Obesity pillars. 2023 Article GET IT
-
Pharmacologic management of weight regain following bariatric surgery.
Frontiers in endocrinology.
2023
Academic Article
GET IT
Times cited: 26 -
Weight Loss Outcomes With Telemedicine During COVID-19.
Frontiers in endocrinology.
2022
Academic Article
GET IT
Times cited: 17 -
Long-term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study.
Obesity science & practice.
2021
Academic Article
GET IT
Times cited: 13 -
Obesity and Diabetes.
The Nursing clinics of North America.
2021
Information Resource
GET IT
Times cited: 98 -
A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss.
Obesity (Silver Spring, Md.).
2021
Information Resource
GET IT
Times cited: 70 -
Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults.
Expert opinion on pharmacotherapy.
2021
Information Resource
GET IT
Times cited: 4 -
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.
Journal of diabetes and its complications.
2021
Academic Article
GET IT
Times cited: 6 -
Impact of Telemedicine During the COVID-19 Pandemic on Patient Attendance.
Obesity (Silver Spring, Md.).
2021
Article
GET IT
Times cited: 13 -
The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.
Obesity (Silver Spring, Md.).
2021
Academic Article
GET IT
Times cited: 23 -
An update on pharmacotherapeutic strategies for obesity.
Expert opinion on pharmacotherapy.
2021
Information Resource
GET IT
Times cited: 10 -
Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
Obesity research & clinical practice.
2020
Academic Article
GET IT
Times cited: 20 -
Best Practices in the Management of Overweight and Obesity.
The Medical clinics of North America.
2020
Information Resource
GET IT
Times cited: 71 -
Medical Weight-Loss Outcomes in Patients Receiving Concomitant Psychotropic Medication: A Retrospective Cohort Study.
Obesity (Silver Spring, Md.).
2020
Academic Article
GET IT
Times cited: 5 -
Surgical and Nonsurgical Weight Loss for Patients with Obstructive Sleep Apnea.
Otolaryngologic clinics of North America.
2020
Information Resource
GET IT
Times cited: 15 -
An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity.
Expert opinion on pharmacotherapy.
2019
Information Resource
GET IT
Times cited: 12 -
Long-Term Modulation of Appetitive Hormones and Sweet Cravings After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass.
Obesity surgery.
2019
Academic Article
GET IT
Times cited: 41 -
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.
Expert opinion on biological therapy.
2015
Information Resource
GET IT
Times cited: 21 -
RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Oncogene.
2012
Academic Article
GET IT
Times cited: 179